177 related articles for article (PubMed ID: 33666857)
1. Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells.
Gozlan EC; Chobrutskiy BI; Zaman S; Yeagley M; Blanck G
J Mol Neurosci; 2021 Nov; 71(11):2393-2404. PubMed ID: 33666857
[TBL] [Abstract][Full Text] [Related]
2. Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
Kacsoh DB; Diaz MJ; Gozlan EC; Sahoo A; Song JJ; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12047-12056. PubMed ID: 37421457
[TBL] [Abstract][Full Text] [Related]
3. Delineation of a T-cell receptor CDR3-cancer mutanome aromaticity factor, assessable via blood samples, that facilitates the establishment of survival distinctions in bladder cancer.
Waweru JW; Mwangi KW; Barker VR; Gozlan EC; Yeagley M; Blanck G; Makokha FW
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4359-4366. PubMed ID: 36098856
[TBL] [Abstract][Full Text] [Related]
4. Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.
Mcbreairty BE; Chobrutskiy BI; Chobrutskiy A; Gozlan EC; Diaz MJ; Blanck G
Biomed Rep; 2022 Aug; 17(2):68. PubMed ID: 35815190
[TBL] [Abstract][Full Text] [Related]
5. Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes.
Gozlan EC; Chobrutskiy BI; Blanck G
Int J Lab Hematol; 2022 Oct; 44(5):883-891. PubMed ID: 35527672
[TBL] [Abstract][Full Text] [Related]
6. Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma.
Kacsoh DB; Patel DN; Hsiang M; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Mol Neurosci; 2022 Sep; 72(9):2011-2019. PubMed ID: 35896862
[TBL] [Abstract][Full Text] [Related]
7. Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma.
Cios KJ; Huda TI; Eakins RA; Mihyu MM; Blanck G
Leuk Lymphoma; 2022 Jun; 63(6):1314-1322. PubMed ID: 35019822
[TBL] [Abstract][Full Text] [Related]
8. High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer.
Chobrutskiy BI; Chobrutskiy A; Zaman S; Yeagley M; Huda TI; Blanck G
Mol Immunol; 2021 Jul; 135():247-253. PubMed ID: 33933816
[TBL] [Abstract][Full Text] [Related]
9. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
[TBL] [Abstract][Full Text] [Related]
10. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Hudock TR; Barker VR; Manley BJ; Chobrutskiy A; Chobrutskiy BI; Diaz MJ; Song JJ; Blanck G
Cancer Biomark; 2023; 38(1):103-110. PubMed ID: 37545223
[TBL] [Abstract][Full Text] [Related]
11. Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.
Mwangi KW; Kamita MK; Waweru JW; Sayed S; Figueroa JD; Ambs S; Cios KJ; Blanck G; Makokha FW
Breast Cancer Res Treat; 2023 May; 199(1):207-214. PubMed ID: 36882607
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma.
Jin W; Zhang Y; Liu Z; Che Z; Gao M; Peng H
J Cell Physiol; 2021 Jan; 236(1):294-308. PubMed ID: 32510620
[TBL] [Abstract][Full Text] [Related]
13. Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma.
Bauer DF; Pereboeva L; Gillespie GY; Cloud GA; Elzafarany O; Langford C; Markert JM; Lamb LS
J Immunol Res; 2016; 2016():2568125. PubMed ID: 27610392
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the diversity of T cell receptor γδ complementary determinant region 3 in human peripheral blood by Immune Repertoire Sequencing.
Chen H; Zou M; Teng D; Zhang J; He W
J Immunol Methods; 2017 Apr; 443():9-17. PubMed ID: 28159550
[TBL] [Abstract][Full Text] [Related]
15. Immunological landscape of Neuroblastoma and its clinical significance.
Batchu S
Cancer Treat Res Commun; 2021; 26():100274. PubMed ID: 33338852
[TBL] [Abstract][Full Text] [Related]
16. IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities.
Charkowick SV; Huda TI; Patel DN; Yeagley M; Arturo JF; Cios KJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biochem Genet; 2024 Feb; 62(1):530-546. PubMed ID: 37392243
[TBL] [Abstract][Full Text] [Related]
17. Immune DNA signature of T-cell infiltration in breast tumor exomes.
Levy E; Marty R; Gárate Calderón V; Woo B; Dow M; Armisen R; Carter H; Harismendy O
Sci Rep; 2016 Jul; 6():30064. PubMed ID: 27452728
[TBL] [Abstract][Full Text] [Related]
18. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
Huda TI; Diaz MJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Alzheimers Dis; 2022; 88(2):619-629. PubMed ID: 35662120
[TBL] [Abstract][Full Text] [Related]
19. Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas.
Yeagley M; Chobrutskiy BI; Gozlan EC; Medikonda N; Patel DN; Falasiri S; Callahan BM; Huda T; Blanck G
Pediatr Hematol Oncol; 2021 Apr; 38(3):251-264. PubMed ID: 33616477
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
Yu Y; Zeng Y; Xia X; Zhou JG; Cao F
Cancer Control; 2021; 28():10732748211033751. PubMed ID: 34569303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
